25051961 |
Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and α2β1-mediated collagen binding in thrombus formation
Nieswandt, B,
Stegner, D,
Mewburn, J,
Brown, C,
Vidal, B,
Lillicrap, D,
Rydz, N,
Shida, Y,
Danisment, O,
Sponagle, K,
Hegadorn, CA,
Pruss, CM,
Crawford, B
|
Blood |
2014 |
19687512 |
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor
Gill, S,
McKinnon, TA,
Mellars, G,
Sutherland, M,
Riddell, AF,
Brown, SA,
Laffan, MA,
Gomez, K,
Millar, CM
|
Blood |
2009 |
20345715 |
Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD
Montgomery, RR,
Christopherson, PA,
Friedman, KD,
Hoffmann, RG,
Flood, VH,
Lederman, CA,
Wren, JS
|
J Thromb Haemost |
2010 |
34758185 |
Von Willebrand disease type 2M: Correlation between genotype and phenotype
Simons, A,
Brons, PPT,
Blijlevens, NMA,
Meijer, D,
Nieuwenhuizen, L,
Schols, SEM,
Krouwel, S,
Laros-van Gorkom, BAP,
van Heerde, WL,
Atiq, F,
Leebeek, FWG,
Schoormans, SCM,
Maas, DPMSM
|
J Thromb Haemost |
2022 |